Buscar
-
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing
(Nature Genetics. vol. 51, n° 3, pp. 414-430, 2019-03)Article de revue -
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
(Science Immunology. vol. 6, n° 62, 2021-08-19)Article de revueLibre acceso -
ESO Guideline on covert cerebral small vessel disease
(European Stroke Journal, 2021-05-11)Article de revueLibre acceso -
Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation
(Molecular Psychiatry. vol. 25, n° 8, pp. 1859-1875, 2020-08)Article de revueLibre acceso -
27-year time trends in dementia incidence in Europe and the US: the Alzheimer Cohorts Consortium
(Neurology. vol. 95, n° 5, pp. e519-e531, 2020-08-04)Article de revueLibre acceso -
Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia
(Obesity Reviews. vol. 21, n° 4, pp. e12989, 2020)Article de revueLibre acceso -
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
(Journal of Experimental Medicine. vol. 219, n° 11, 2022-11-07)Article de revueLibre acceso -
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
(Proceedings of the National Academy of Sciences of the United States of America. vol. 120, n° 36, pp. e2302720120, 2023-09-05)Article de revueLibre acceso -
A second update on mapping the human genetic architecture of COVID-19
(Nature. vol. 621, n° 7977, pp. E7-E26, 2023-09-01)Article de revueLibre acceso